Nasopharyngeal Cancer Drug Market - Global Outlook and Forecast 2021-2027

Code: RW00014560605
Market Monitor Global
Oct-2021
Life Sciences
104 Pages

This report contains market size and forecasts of Nasopharyngeal Cancer Drug in global, including the following market information:
Global Nasopharyngeal Cancer Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Nasopharyngeal Cancer Drug Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Nasopharyngeal Cancer Drug companies in 2020 (%)
The global Nasopharyngeal Cancer Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nasopharyngeal Cancer Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nasopharyngeal Cancer Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Nasopharyngeal Cancer Drug Market Segment Percentages, By Type, 2020 (%)
BGBA-317
CBT-501
Apatinib
APG-1387
ARGX-110
ATA-129
Others

Global Nasopharyngeal Cancer Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Nasopharyngeal Cancer Drug Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others

Global Nasopharyngeal Cancer Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Nasopharyngeal Cancer Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nasopharyngeal Cancer Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Nasopharyngeal Cancer Drug revenues share in global market, 2020 (%)
Key companies Nasopharyngeal Cancer Drug sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Nasopharyngeal Cancer Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ambrx Inc
arGEN-X BV
Atara Biotherapeutics Inc
AVEO Pharmaceuticals Inc
BeiGene Ltd
BioDiem Ltd
Biomics Biotechnologies Co Ltd
Bristol-Myers Squibb Company
CBT Pharmaceuticals Inc
Celgene Corp
Cell Medica Ltd
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Nasopharyngeal Cancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nasopharyngeal Cancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nasopharyngeal Cancer Drug Overall Market Size
2.1 Global Nasopharyngeal Cancer Drug Market Size: 2021 VS 2027
2.2 Global Nasopharyngeal Cancer Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Nasopharyngeal Cancer Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Nasopharyngeal Cancer Drug Players in Global Market
3.2 Top Global Nasopharyngeal Cancer Drug Companies Ranked by Revenue
3.3 Global Nasopharyngeal Cancer Drug Revenue by Companies
3.4 Global Nasopharyngeal Cancer Drug Sales by Companies
3.5 Global Nasopharyngeal Cancer Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Nasopharyngeal Cancer Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Nasopharyngeal Cancer Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nasopharyngeal Cancer Drug Players in Global Market
3.8.1 List of Global Tier 1 Nasopharyngeal Cancer Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Nasopharyngeal Cancer Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Nasopharyngeal Cancer Drug Market Size Markets, 2021 & 2027
4.1.2 BGBA-317
4.1.3 CBT-501
4.1.4 Apatinib
4.1.5 APG-1387
4.1.6 ARGX-110
4.1.7 ATA-129
4.1.8 Others
4.2 By Type - Global Nasopharyngeal Cancer Drug Revenue & Forecasts
4.2.1 By Type - Global Nasopharyngeal Cancer Drug Revenue, 2016-2021
4.2.2 By Type - Global Nasopharyngeal Cancer Drug Revenue, 2022-2027
4.2.3 By Type - Global Nasopharyngeal Cancer Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Nasopharyngeal Cancer Drug Sales & Forecasts
4.3.1 By Type - Global Nasopharyngeal Cancer Drug Sales, 2016-2021
4.3.2 By Type - Global Nasopharyngeal Cancer Drug Sales, 2022-2027
4.3.3 By Type - Global Nasopharyngeal Cancer Drug Sales Market Share, 2016-2027
4.4 By Type - Global Nasopharyngeal Cancer Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nasopharyngeal Cancer Drug Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Nasopharyngeal Cancer Drug Revenue & Forecasts
5.2.1 By Application - Global Nasopharyngeal Cancer Drug Revenue, 2016-2021
5.2.2 By Application - Global Nasopharyngeal Cancer Drug Revenue, 2022-2027
5.2.3 By Application - Global Nasopharyngeal Cancer Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Nasopharyngeal Cancer Drug Sales & Forecasts
5.3.1 By Application - Global Nasopharyngeal Cancer Drug Sales, 2016-2021
5.3.2 By Application - Global Nasopharyngeal Cancer Drug Sales, 2022-2027
5.3.3 By Application - Global Nasopharyngeal Cancer Drug Sales Market Share, 2016-2027
5.4 By Application - Global Nasopharyngeal Cancer Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Nasopharyngeal Cancer Drug Market Size, 2021 & 2027
6.2 By Region - Global Nasopharyngeal Cancer Drug Revenue & Forecasts
6.2.1 By Region - Global Nasopharyngeal Cancer Drug Revenue, 2016-2021
6.2.2 By Region - Global Nasopharyngeal Cancer Drug Revenue, 2022-2027
6.2.3 By Region - Global Nasopharyngeal Cancer Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Nasopharyngeal Cancer Drug Sales & Forecasts
6.3.1 By Region - Global Nasopharyngeal Cancer Drug Sales, 2016-2021
6.3.2 By Region - Global Nasopharyngeal Cancer Drug Sales, 2022-2027
6.3.3 By Region - Global Nasopharyngeal Cancer Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Nasopharyngeal Cancer Drug Revenue, 2016-2027
6.4.2 By Country - North America Nasopharyngeal Cancer Drug Sales, 2016-2027
6.4.3 US Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.4.4 Canada Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.4.5 Mexico Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Nasopharyngeal Cancer Drug Revenue, 2016-2027
6.5.2 By Country - Europe Nasopharyngeal Cancer Drug Sales, 2016-2027
6.5.3 Germany Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.5.4 France Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.5.5 U.K. Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.5.6 Italy Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.5.7 Russia Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.5.8 Nordic Countries Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.5.9 Benelux Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Nasopharyngeal Cancer Drug Revenue, 2016-2027
6.6.2 By Region - Asia Nasopharyngeal Cancer Drug Sales, 2016-2027
6.6.3 China Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.6.4 Japan Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.6.5 South Korea Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.6.6 Southeast Asia Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.6.7 India Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Nasopharyngeal Cancer Drug Revenue, 2016-2027
6.7.2 By Country - South America Nasopharyngeal Cancer Drug Sales, 2016-2027
6.7.3 Brazil Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.7.4 Argentina Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nasopharyngeal Cancer Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Nasopharyngeal Cancer Drug Sales, 2016-2027
6.8.3 Turkey Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.8.4 Israel Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Nasopharyngeal Cancer Drug Market Size, 2016-2027
6.8.6 UAE Nasopharyngeal Cancer Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Ambrx Inc
7.1.1 Ambrx Inc Corporate Summary
7.1.2 Ambrx Inc Business Overview
7.1.3 Ambrx Inc Nasopharyngeal Cancer Drug Major Product Offerings
7.1.4 Ambrx Inc Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.1.5 Ambrx Inc Key News
7.2 arGEN-X BV
7.2.1 arGEN-X BV Corporate Summary
7.2.2 arGEN-X BV Business Overview
7.2.3 arGEN-X BV Nasopharyngeal Cancer Drug Major Product Offerings
7.2.4 arGEN-X BV Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.2.5 arGEN-X BV Key News
7.3 Atara Biotherapeutics Inc
7.3.1 Atara Biotherapeutics Inc Corporate Summary
7.3.2 Atara Biotherapeutics Inc Business Overview
7.3.3 Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Major Product Offerings
7.3.4 Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.3.5 Atara Biotherapeutics Inc Key News
7.4 AVEO Pharmaceuticals Inc
7.4.1 AVEO Pharmaceuticals Inc Corporate Summary
7.4.2 AVEO Pharmaceuticals Inc Business Overview
7.4.3 AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Major Product Offerings
7.4.4 AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.4.5 AVEO Pharmaceuticals Inc Key News
7.5 BeiGene Ltd
7.5.1 BeiGene Ltd Corporate Summary
7.5.2 BeiGene Ltd Business Overview
7.5.3 BeiGene Ltd Nasopharyngeal Cancer Drug Major Product Offerings
7.5.4 BeiGene Ltd Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.5.5 BeiGene Ltd Key News
7.6 BioDiem Ltd
7.6.1 BioDiem Ltd Corporate Summary
7.6.2 BioDiem Ltd Business Overview
7.6.3 BioDiem Ltd Nasopharyngeal Cancer Drug Major Product Offerings
7.6.4 BioDiem Ltd Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.6.5 BioDiem Ltd Key News
7.7 Biomics Biotechnologies Co Ltd
7.7.1 Biomics Biotechnologies Co Ltd Corporate Summary
7.7.2 Biomics Biotechnologies Co Ltd Business Overview
7.7.3 Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Major Product Offerings
7.4.4 Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.7.5 Biomics Biotechnologies Co Ltd Key News
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Corporate Summary
7.8.2 Bristol-Myers Squibb Company Business Overview
7.8.3 Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Major Product Offerings
7.8.4 Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.8.5 Bristol-Myers Squibb Company Key News
7.9 CBT Pharmaceuticals Inc
7.9.1 CBT Pharmaceuticals Inc Corporate Summary
7.9.2 CBT Pharmaceuticals Inc Business Overview
7.9.3 CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Major Product Offerings
7.9.4 CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.9.5 CBT Pharmaceuticals Inc Key News
7.10 Celgene Corp
7.10.1 Celgene Corp Corporate Summary
7.10.2 Celgene Corp Business Overview
7.10.3 Celgene Corp Nasopharyngeal Cancer Drug Major Product Offerings
7.10.4 Celgene Corp Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.10.5 Celgene Corp Key News
7.11 Cell Medica Ltd
7.11.1 Cell Medica Ltd Corporate Summary
7.11.2 Cell Medica Ltd Nasopharyngeal Cancer Drug Business Overview
7.11.3 Cell Medica Ltd Nasopharyngeal Cancer Drug Major Product Offerings
7.11.4 Cell Medica Ltd Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.11.5 Cell Medica Ltd Key News
7.12 F. Hoffmann-La Roche Ltd
7.12.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.12.2 F. Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Business Overview
7.12.3 F. Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Major Product Offerings
7.12.4 F. Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.12.5 F. Hoffmann-La Roche Ltd Key News
7.13 GlaxoSmithKline Plc
7.13.1 GlaxoSmithKline Plc Corporate Summary
7.13.2 GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Business Overview
7.13.3 GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Major Product Offerings
7.13.4 GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Sales and Revenue in Global (2016-2021)
7.13.5 GlaxoSmithKline Plc Key News
8 Global Nasopharyngeal Cancer Drug Production Capacity, Analysis
8.1 Global Nasopharyngeal Cancer Drug Production Capacity, 2016-2027
8.2 Nasopharyngeal Cancer Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Nasopharyngeal Cancer Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nasopharyngeal Cancer Drug Supply Chain Analysis
10.1 Nasopharyngeal Cancer Drug Industry Value Chain
10.2 Nasopharyngeal Cancer Drug Upstream Market
10.3 Nasopharyngeal Cancer Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nasopharyngeal Cancer Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Nasopharyngeal Cancer Drug in Global Market
Table 2. Top Nasopharyngeal Cancer Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Nasopharyngeal Cancer Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Nasopharyngeal Cancer Drug Revenue Share by Companies, 2016-2021
Table 5. Global Nasopharyngeal Cancer Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Nasopharyngeal Cancer Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Nasopharyngeal Cancer Drug Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Nasopharyngeal Cancer Drug Product Type
Table 9. List of Global Tier 1 Nasopharyngeal Cancer Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nasopharyngeal Cancer Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Ambrx Inc
arGEN-X BV
Atara Biotherapeutics Inc
AVEO Pharmaceuticals Inc
BeiGene Ltd
BioDiem Ltd
Biomics Biotechnologies Co Ltd
Bristol-Myers Squibb Company
CBT Pharmaceuticals Inc
Celgene Corp
Cell Medica Ltd
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE